Repository for study on nephrotic syndrome anti-CD20 antibodies treatment
This repository contains code used to identify cohorts for the Nephrotic Syndrome Anti-CD20 Antibodies descriptive study, and includes the following steps:
- Implement the glomerular disease phenotype
- Identify nephrotic subcohorts
- Remove patients with at least one diagnosis flagged as genetic or congenital
- Identify cohort of patients with Systemic Lupus Erythematosus (SLE) to be applied as an exclusion criterion
- Exclude SLE patients
- Identify kidney biopsy status